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Fluorescence recovery after photobleachingBacillus cereus sphingomyelinase (Bc-SMase) induces hemolysis of sheep erythrocytes which contain large
amounts of sphingomyelin. We investigated the mechanism of this hemolysis in comparison to that induced
by Clostridium perfringens alpha-toxin. Pertussis toxin, a Gi-speciﬁc inhibitor, N-oleoylethernolamine, a
ceramidase inhibitor, and dihydrosphingosine, a sphingosine kinase inhibitor, did not inhibit the hemolysis
by Bc-SMase, but did inhibit that by alpha-toxin. Bc-SMase broadly bound to whole membranes, and alpha-
toxin speciﬁcally bound to the detergent-resistant membrane fractions, lipid rafts. The level of ceramide
production induced by Bc-SMase in sheep erythrocytes was 6- to 15-fold that induced by alpha-toxin, when
the extent of the hemolysis by Bc-SMase was the same as that by the toxin. However, the level of ceramide
production induced by Bc-SMase in SM-liposomes was equal to that triggered by the toxin, when the
carboxyl ﬂuorescein-release from liposomes induced by Bc-SMase was the same as that induced by alpha-
toxin. Confocal laser microscopy showed that treatment of the cells with Bc-SMase resulted in the formation
of ceramide-rich domains. A photobleaching analysis suggested that treatment of the cells with Bc-SMase
leads to a reduction in membrane ﬂuidity. These results show that Bc-SMase-induced hemolysis of sheep
erythrocytes is related to the formation of interface between ceramide-rich domains and ceramide-poor
domains through production of ceramide from SM.cillus cereus sphingomyelinase;
t-resistant membranes; DSF,
ingosine 1-phosphate; MβCD,
ertussis toxin; DHS, dihydro-
recovery after photobleaching
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Sphingomyelinase (SMase) is an enzyme which hydrolyses
sphingomyelin (SM) to ceramide and phosphocholine. Several types
of enzyme with SMase activity have been identiﬁed in eukaryotes and
prokaryotes. Eukaryotic SMases have been classiﬁed according to
their pH optima, as acid [1], alkaline [2], and neutral SMases
(nSMases) [3,4]. Several pathogenic bacteria, such as Staphylococcus
aureus [5], Bacillus cereus [6], Leptospira interrogans [7], and Listeria
ivanovii [8], produce SMases. These bacterial SMases share sequence
homology with eukaryotic nSMases. These observations suggest that
bacterial and eukaryotic nSMases share a similar catalytic mechanism
and overall structure [9,10].
SMase from Bacillus cereus (Bc-SMase) with a molecular mass of
34 kDa exhibits enzymatic and hemolytic activities [11]. The enzyme
binds speciﬁcally to membranes of sheep erythrocytes and selectively
hydrolyses SM in membranes of the erythrocytes. It has been repor-
ted that Ca2+ and Mn2+ enhanced binding of the enzyme to theerythrocyte membranes, whereas Mg2+ accelerated hemolytic ac-
tivity together with the breakdown of SM [3,12–14]. We reported that
divalent metal ions were effective in stimulating the activity of Bc-
SMase in the order Co2+≥Mn2+≥Mg2+≫Ca2+≥Sr2+, and resolved
the structure of Bc-SMase bound to Co2+, Mg2+ or Ca2+ [15]. A crystal
analysis showed that Bc-SMase has two metal ion-binding sites in a
long horizontal cleft across the molecule; the central region of the
cleft is the binding-site of one Mg2+ or two Co2+ and the side of the
cleft is the binding-site of one divalent metal ion [15].We also showed
that the metal ions in the central region play an important role in the
enzymatic activity of Bc-SMase. However, the role of the metal ions at
the side remains unclear. We also provided evidence that the exposed
loop fromAsn-92 to Pro-98 participates in the binding to the substrate
and perhaps membranes [15].
Little is known about how the mechanism of hemolysis of sheep
erythrocytes is induced by Bc-SMase. We have reported that the
alpha-toxin-induced hemolysis of rabbit erythrocytes is due to
activation of the metabolism of glycerophospholipids through a
GTP-binding protein [16,17], and that the toxin triggers hemolysis
though the activation of an endogenous SMase via a GTP-binding
protein in sheep erythrocytes [18]. Furthermore, we reported that
alpha-toxin-induced activation of the metabolism of C24:1-SM
through Gi in detergent-resistant membrane fractions (DRM) of
sheep erythrocytes, especially the formation of S1P, is closely involved
in hemolysis [19]. Therefore, to elucidate the mechanism of hemolysis
by Bc-SMase, we compared it with that induced by alpha-toxin.
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2.1. Drugs
Sheep erythrocytes were purchased from Nippon Bio-Test Labo-
ratories, Japan. N-oleoylethanolamine (N-OE), cardiolipin, methyl-β-
cyclodextrin (MβCD) and 5(6)-carboxyﬂuorescein diacetate (CF)
were obtained from Sigma-Aldrich Chemical, USA. Dihydrosphingo-
sine (DHS) was from Calbiochem-Novabiochem, USA. Leupeptin and
pepstatin were obtained from Chemicon International, USA. 1-O-n-
Octyl-β-D-glucopyranoside was purchased from Nacalai Tesque,
Japan. [γ-32P]ATP (4,500 Ci/mmol) was supplied by ICN Biochemicals,
USA. All other drugs were of analytical grade.
2.2. Preparation of B. cereus sphingomyelinase and the variant enzyme
(E53A)
The expression and puriﬁcation of recombinant Bc-SMase and
E53A were performed as described previously [15].
2.3. Site-directed mutagenesis
The transformer site-directed mutagenesis kit (BD Biosciences,
USA) was used with the primer E53A: GTTATTTTAAATGCCGTGTTT-
GATAATAGC, to prepare the modiﬁed plasmid. The genetic sequence
of Bc-SMase in each plasmid was conﬁrmed with an ABI310 PRISM™
genetic analyzer (Applied Biosystems, USA).
2.4. Preparation of C. perfringens alpha-toxin and the variant enzyme
(H148G)
The expression and puriﬁcation of recombinant alpha-toxin and
H148G were performed as described previously [18].
2.5. Preparation of sheep erythrocytes
Sheep erythrocytes were suspended in 0.02 M Tris–HCl buffer
(pH 7.5) containing 0.9% NaCl (TBS), and centrifuged at 1100 ×g for
3 min. The erythrocytes were washed by the centrifugation three
times. The number of erythrocytes was determinedwith a cell counter
(Celltac; Nihon Kohden, Japan).
2.6. Determination of hemolytic activity
Bc-SMase or alpha-toxin was incubated with sheep erythrocytes
(12×1010 cells/ml) in TBS at 37 °C for 30 min, and the cells were
chilled at 4 °C. The hemolysis of the erythrocytes was measured, as
described previously [18]. Hemolysis was expressed as a percentage
of the amount of hemoglobin released from 0.1 ml of erythrocytes
suspended in 0.4 ml of 0.4% NaCl.
2.7. Determination of ceramide
Levels of ceramide in the erythrocytes treated with Bc-SMase or
alpha-toxin were measured as described previously [18].
2.8. Sucrose gradient fractionation
Separation of DRM was carried out by ﬂotation-centrifugation
with a sucrose gradient. Sheep erythrocytes were incubated with
40 μM of E53A (Bc-SMase mutant) or H148G (alpha-toxin mutant) at
37 °C for various periods in TBS containing 0.25% (w/v) gelatin
(GTBS). The cells were washed with TBS and treated with 0.5% Triton
X-100 for 30 min at 4 °C in TBS containing the protease inhibitor
cocktail (Nacalai Tesque) and sonicated for 30-s pulses using a tip-
type sonicator. The lysates were adjusted to 40% sucrose (w/v),overlaid with 2.4 ml of 36% sucrose and 1.2 ml of 5% sucrose in TBS,
centrifuged at 45,000 rpm (250,000 ×g) at 4 °C for 18 h in a SW55
rotor (Beckman Instruments, USA), and fractionated from the top
(0.4 ml each, a total of 10 fractions). The aliquots were subjected to
SDS-PAGE and Western blotting using each speciﬁc antibody.2.9. Immunoblot analysis of DRM marker proteins
Aliquots of the ﬂotation sucrose gradient fractions were heated in
2% SDS-sample buffer at 100 °C for 3 min. The samples were
electrophoresed on an SDS-PAGE gel, and transferred to a poly-
vinylidene diﬂuoride membrane. The membrane was blocked with
TBS containing 2% Tween 20 and 5% skim milk and incubated with a
primary antibody such as anti-alpha-toxin (1:1000), anti-Bc-SMase
(1:1000), or anti-ﬂotilin-1 (1:1000) in TBS containing 1% skim milk,
then with a horseradish peroxidase-conjugated secondary antibody,
and ﬁnally with an enhanced chemiluminescence analysis kit
(GE health science, USA). The level of cholesterol was assayed
spectrophotometrically using a diagnostic kit (Cholesterol C-test;
Wako, Japan).2.10. Preparation of liposomes
SM (Nacalai Tesque) from bovine brain and cholesterol (1:1) in
chloroform-methanol (2:1 v/v) were dried with N2 gas, resuspended
in TBS containing 0.1 M CF. The liposome suspensions were cen-
trifuged at 22,000 ×g for 15 min at 4 °C to remove the nonencapsu-
lated marker, and washed three times by centrifugation. The resulting
liposomes were suspended in 200 μl of TBS.2.11. The SM-liposome-disruption activity
The SM-liposome-disruption activity was evaluated at the amount
of released-CF in the test aliquot. The SM-liposomes in TBS containing
1 mMMgCl2 were incubated with Bc-SMase or alpha-toxin for 30 min
at 37 °C. 100% CF release was deﬁned as the ﬂuorescence intensity
that was gained upon exposure of liposomes to 2% Triton X-100 at
37 °C for 30 min.2.12. Fluorescence microscopy
A confocal ﬂuorescence microscope (A1; Nikon, Japan) was used.
The excitation wavelength was 488 nm for BODIPY FL C12-SM
(Molecular probes, USA) (BODIPY-SM). The ﬂuorescence signals
were simultaneously collected using NIS-Elements C (Nikon soft-
ware) into a channel using bandpass ﬁlters of 525/50. The objective
used in all experiments was a 60× oil immersion, CFI Plan Apo VC 60×
oil/1.40 objective (Nikon). The objective lens was used with a zoom
factor of 2. The experiments were performed at room temperature.2.13. Fluorescence recovery after photobleaching
Fluorescence recovery after photobleaching (FRAP), a technology
used to measure the lateral mobility of membranes, was performed
with a Nikon A1R confocal laser scanningmicroscope, according to the
manual. Sheep erythrocytes stained with 2 μM BODIPY-SM were
plated on 35-mm glass-bottomed dishes (MatTek, USA). The treated
cells were spread on 0.3% agar containing TBS. The photobleaching
was performed in a 1.5 μm, visually uniform region of the cell
membranes. Bleaching was performed with 5% laser intensity for a
duration of approximately 1 s (5 scans of the laser) to achieve 50%
bleaching of the BODIPY ﬂuorescence. After photobleaching, images
were acquired 200 times at 1-s intervals.
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Sheep erythrocytes (15×1010 cells/ml) were stained with 2 μM
BODIPY-SM. The cells were incubated with Bc-SMase in GTBS at 37 °C
for 30 min, and the reaction was stopped by chloroform-methanol
(2:1). The lipids were extracted by the method as reported previously
[19]. The extracted lipids were developed by normal-phase TLC with
chloroform-methanol-DW (65:25:4, v/v). Labeled lipids on the plate
were visualized with a Bio-Imaging Analyzer FLA-2000 using the
following ﬁlter: excitation 473 nm and emission 580 nm (Fujiﬁlm Co.,
Tokyo, Japan). The mobility of BODIPY-labeled SM and ceramide on
TLC corresponded to that of SM from bovine brain and C24:1-ceramide
(Avanti Polar Lipid, USA).2.15. Immunoﬂuorescence staining and confocal imaging
Sheep erythrocytes (15×1010 cells/ml) were stained with 2 μM
BODIPY-SM. The cells were incubated with Bc-SMase in GTBS at 37 °C
for 30 min, and the reactionwas stopped by 1.0% paraformaldehyde at
room temperature. For antibody labeling, the cells were incubated at
room temperature for 10 min in 50 mM NH4Cl in phosphate buffered
saline (PBS). After being washed with PBS, the cells were incubated at
room temperature for 60 min with PBS containing 4% BSA, followed
bymouse anti-ceramide antibody in PBS for 60 min. After a wash with
PBS, the cells were incubated at room temperature for 60 min with
Alexa Fluor 546-conjugated anti-mouse IgG. The treated cells were
spread on 0.3% agar containing TBS.2.16. Statistical analysis
All values are expressed as means±SEM. The signiﬁcance dif-
ferences between experimental and control groups were determined
with Student's t-test. Pb0.01 was considered statistically signiﬁcant.Fig. 1. Effect of several inhibitors on the hemolysis of sheep erythrocytes by Bc-SMase or
alpha-toxin. Sheep erythrocytes (15×1010 cells/ml) were preincubated with various
concentrations of PT (A), N-OE (B), or DHS (C) at 37 °C for 120, 60, and 30 min,
respectively, then incubated with 0.8 μM of alpha-toxin (●) or Bc-SMase (○) in TBS
containing 0.3 mM CaCl2 at 37 °C for 30 min, and chilled at 4 °C for 10 min. Values are
means±standard deviations for six independent experiments. *Pb0.01 compared with
hemolysis induced by Bc-SMase or alpha-toxin alone.3. Results
3.1. Effect of pertussis toxin on hemolysis by Bc-SMase and alpha-toxin
We reported that the hemolysis of sheep erythrocytes by alpha-
toxin was dependent on the activation of endogenous SMase via Gi
[18]. PT is a speciﬁc inhibitor of signal transduction via Gi [20–22]. Bc-
SMase is known to lyse sheep erythrocytes similar to alpha-toxin
[11,13]. To compare the effect of PT on the hemolysis by Bc-SMase
with that by the toxin, erythrocytes preincubated with various
concentrations of PT were incubated with Bc-SMase or alpha-toxin
at 37 °C for 30 min. As shown in Fig. 1A, PT at concentrations of 5 to
20 μg did not signiﬁcantly inhibit the hemolysis by Bc-SMase, but did
impede that induced by alpha-toxin in a dose-dependent manner. In
addition, Bc-SMase hydrolyzed SM in membranes in the presence of
20 μg of PT, but alpha-toxin mostly did not (data not shown).3.2. Effect of N-OE and DHS on hemolysis induced by Bc-SMase and
alpha-toxin
We tested whether hemolysis induced by Bc-SMase is dependent
on activation of the SM metabolism system. Sheep erythrocytes were
preincubated with various concentrations of N-OE [23], an inhibitor of
ceramidase, or DHS [24], an inhibitor of sphingosine kinase, at 37 °C
for 30 min, and incubated with 0.8 μM of Bc-SMase or alpha-toxin at
37 °C for 30 min. Treatment of sheep erythrocytes with 100 μM N-OE
or 20 μM DHS had little effect on the hemolysis by Bc-SMase.
However, N-OE (12.5 to 75 μM) and DHS (5 to 20 μM) inhibited the
hemolysis by alpha-toxin in a dose-dependentmanner (Fig. 1B and C).3.3. Binding of Bc-SMase to membranes of sheep erythrocytes
It has been reported that bacterial toxins such as C. perfringens beta
toxin [25], perfringolysin O [26] and shiga toxin [27] speciﬁcally bind
to DRM which are implicated in signal transduction. Therefore, to
analyze the binding of Bc-SMase and alpha-toxin to the erythrocyte
membranes, the cells were incubated with E53A (a Bc-SMase mutant)
and H148G (an alpha-toxin mutant), which bind to erythrocytes, but
do not contain the hemolytic and enzymatic activities of PLC and/or
SMase [28,29], at 37 °C for 15 min, and treated with 1% TritonX-100 at
4 °C. The Triton X-100-insoluble components were fractionated by
sucrose density gradient centrifugation. The fractions were subjected
to SDS-PAGE and Western blotting. When the DRM marker in the
fractions obtained by the centrifugation was analyzed using anti-
ﬂotillin-1, ﬂotillin-1 was detected in the low density fractions
(fractions 3–5) and the fractions with a much higher proportion of
cholesterol (Fig. 2A). As shown in Fig. 2A, E53A was detected in whole
membranes, from DRM (fractions 3–5) to detergent-soluble fractions
(DSF, fractions 6–10), and H148G was detected in DRM. The result
suggests that Bc-SMase broadly binds to sheep erythrocyte mem-
branes, and the toxin binds to the lipid rafts.
Fig. 2. The binding of Bc-SMase or alpha-toxin tomembrane of sheep erythrocytes. (A) Sheep erythrocytes (15×1010 cells/ml) were incubated with E53A (40 μM) or H148G (40 μM)
in GTBS at 37 °C for 30 min and fractionated by sucrose gradient ultracentrifugation. Fractions were collected from the top and subjected to SDS-PAGE, followed byWestern blotting
using speciﬁc antibodies. The amount of cholesterol in the fractions was determined as described in Materials and methods. (B) Sheep erythrocytes (15×1010 cells/ml) were
pretreated with (c, e) or without (a, b, d) 10 μg/ml of PT at 37 °C for 120 min. The treated erythrocytes were incubated with Bc-SMase (b, c) or alpha-toxin (d, e) at 37 °C for 30 min.
The Triton X-100-insoluble fractions were separated by sucrose density ultracentrifugation. Ceramide in the fractions was separated by TLC. A typical result from one of ﬁve
experiments is shown.
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production of ceramide from SM in DRM. We reported that ceramide
produced on treatment with the toxin was readily hydrolyzed to
sphingosine by ceramidase [18]. Therefore, sheep erythrocytes
pretreated with N-OE were incubated with Bc-SMase or alpha-toxin
at 37 °C for 30 min. As shown in Fig. 2B, ceramide in the cells treated
with Bc-SMase was detected in not only DRM, but also DSF. The
formation of ceramide induced by Bc-SMase was not inhibited by PT.
On the other hand, the ceramide produced in the cells treatedwith the
toxin was mainly detected in DRM. PT inhibited the alpha-toxin-
induced formation of ceramide in DRM (Fig. 2B).
3.4. Effect of MβCD on Bc-SMase- or alpha-toxin-induced hemolysis
It has been reported that MβCD selectivity encapsulates choles-
terol in cell membranes, but does not deplete other lipids at
concentrations below 10 mM [30]. The effect of MβCD on Bc-SMase-
or alpha-toxin-induced hemolysis of the erythrocytes was inves-
tigated. The erythrocytes were incubated with various concentrations
of MβCD (2.5–10 mM) at 37 °C for 60 min. The treatment with MβCDresulted in little inhibition of the hemolysis by Bc-SMase, but inhibited
the hemolysis by alpha-toxin in a dose-dependent manner (Fig. 3).
3.5. Comparison of hemolysis by Bc-SMase with that by alpha-toxin of
sheep erythrocytes
We analyzed the relationship between the formation of ceramide
and hemolysis by Bc-SMase and alpha-toxin. The level of hemolysis by
Bc-SMase was the same as that by the toxin at concentrations of 0.05–
0.8 μM, as shown in Fig. 4A and B. The amount of ceramide produced
in response to Bc-SMase was about 6- to 15-fold that produced on
exposure to alpha-toxin under the conditions. Therefore, it appears
that the hemolysis by the former is dependent on the production of
ceramide induced by the enzyme, but that by the latter is not.
3.6. Comparison of the disruption of SM-liposomes by Bc-SMase with
that by alpha-toxin
To investigate the actions of Bc-SMase and the toxin on artiﬁcial
membranes, the amount of CF released from SM-liposomes treated
Fig. 3. Effect of MβCD on Bc-SMase or alpha-toxin-induced hemolysis. Sheep
erythrocytes (15×1010 cells/ml) were preincubated with various concentrations of
MβCD at 37 °C for 60 min and incubated with 0.8 μM Bc-SMase (○) or alpha-toxin
(●) at 37 °C for 30 min, then by chilled at 4 °C for 10 min. Hemolysis (%) was evaluated
as described in the Materials and methods. Values are means±standard deviations for
three independent experiments. *Pb0.01 or **Pb0.005 compared with hemolysis
induced by Bc-SMase or alpha-toxin alone.
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shown in Fig. 5, Bc-SMase and the toxin at concentrations ranging
from 0.5 to 3.0 μM and 3.0 to 30 μM¸ respectively, had similar effect on
CF-release from SM-liposomes and the formation of ceramide in a
dose-dependent manner (Fig. 5), indicating that the ability of Bc-
SMase to hydrolyze SM in membranes was about 10-fold greater than
that of alpha-toxin. Thus, it is likely that the disruption of artiﬁcial
membranes by Bc-SMase and the toxin is dependent on the level of
production of ceramide from SM in membranes.Fig. 4. Comparison of hemolysis and formation of ceramide induced by Bc-SMase or
alpha-toxin. Sheep erythrocytes (15×1010 cells/ml) were incubated with Bc-SMase
(A) or alpha-toxin (B) at 37 °C for 30 min, and chilled at 4 °C for 10 min. Hemolysis and
the formation of ceramide were evaluated as described in Materials and methods.
Values are means±standard deviations for ﬁve independent experiments.
Fig. 5. Comparison of disruption of SM-liposomes and formation of ceramide induced
by Bc-SMase or alpha-toxin. SM-liposomes were incubated with Bc-SMase (A) or alpha-
toxin (B) at 37 °C for 30 min. The disruption of SM-liposomes and formation of cer-
amide were evaluated as described in the Materials and methods. Values are means±
standard deviations for seven independent experiments.3.7. Localization of ceramide in erythrocyte membranes treated with
Bc-SMase
Using confocal microscopy, Montes et al. found that phospholipase
C from Pseudomonas aeruginosa caused the formation of ceramide-
rich domains [31]. To investigate whether Bc-SMase induces the
accumulation of BODIPY-ceramide formed from BODIPY-SM in the
membranes, the erythrocytes stained with BODIPY-SM were incubat-
ed with Bc-SMase or alpha-toxin at 37 °C. Fig. 6A shows sheep
erythrocytes stained with BODIPY-SM. When the erythrocytes were
treated with Bc-SMase, the domains, in which the ﬂuorescent
substances were concentrated, were observed (Fig. 6B, white arrows).
However, ﬂuorescent substance-rich domains were not observed in
membranes of the cells treated with 0.8 μM alpha-toxin (Fig. 6C). As
shown in Fig. 6D, incubation of the BODIPY-SM-stained erythrocytes
with 0.8 μM Bc-SMase resulted in disappearance of BODIPY-SM and
appearance of BODIPY-ceramide in membranes, indicating that
BODIPY-SM in the erythrocytes is almost hydrolyzed to BODIPY-
ceramide by Bc-SMase. Furthermore, treatment of sheep erythrocytes
with 0.8 μM Bc-SMase at 37 °C for 30 min resulted in the hydrolysis of
more than 80% of SM to ceramide in the membranes (data not
shown). We investigated whether the concentrated domain of
ﬂuorescent substances is corresponding to ceramide-rich domain.
BODIPY-SM-stained erythrocytes were incubated with 0.8 μM Bc-
SMase, and ﬁxed with 1% paraformaldehyde. The domains of
ﬂuorescent substances were recognized by anti-ceramide antibody,
whereas erythrocytes stained with BODIPY-SMwere not reacted with
anti-ceramide antibody (Fig. 6E). Treatment of the Bc-SMase-
pretreated cells with 1.0% paraformaldehyde caused morphological
change (shrinkage), but that of untreated cells was not, suggesting
that the nature of membranes of the cells treated with Bc-SMase are
Fig. 6. Confocal ﬂuorescence microscopic analysis of sheep erythrocytes treated with Bc-SMase or alpha-toxin. Sheep erythrocytes stained with BODIPY-SM were incubated without
(A) or with 0.8 μM Bc-SMase (B) or alpha-toxin (C) at 37 °C for 30 min. (D) Identiﬁcation of BODIPY-labeled sphingolipids in BODIPY-stained erythrocytes treated with or without
0.8 μM Bc-SMase. (E) The detection of ceramide-rich domains in BODIPY-stained cells treated with Bc-SMase by anti-ceramide antibody. Fluorescences were viewed with a confocal
laser microscope. A typical result from one of six experiments is shown.
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ﬂuorescent substance-rich domains in the cells treated with Bc-SMase
are ceramide-rich domains.
3.8. FRAP measurements of BODIPY diffusion
Klein et al. [32] reported that membrane ﬂuidity of cells was
evaluated by measurement of lateral diffusion of ﬂuorescence-labeled
SM by FRAPwith a confocal laser microscopy. The BODIPY-SM-stained
erythrocytes were treated with 0.8 μM Bc-SMase, and the rate of
effective diffusion of ﬂuorescence substances in ceramide-rich
domains or ceramide-poor domains (BODIPY-SM) was measured by
FRAP analysis using confocal laser microscopy. Fig. 7B shows a typicalsequence of images from a FRAP measurement of BODIPY diffusion.
The rate of effective diffusion of ﬂuorescent substances at ceramide-
rich domains in erythrocytes treated with Bc-SMase decreased to
about 50%, compared with that of BODIPY-SM in the untreated cells
(Fig. 7B), indicating that the membrane ﬂuidity of the ceramide-rich
domains in the erythrocytes treated with Bc-SMase did not signiﬁ-
cantly recover to control level under the experimental condition.
4. Discussion
The present study demonstrated that Bc-SMase binds to whole
membranes of sheep erythrocytes, and directly hydrolyzes SM in the
membranes, and that the formation of ceramide-rich domains by the
Fig. 7. FRAP analysis of diffusion rate of BODIPY-stained sphingolipids. (A) Bleaching
was performed on a 1.0-μm diameter ROI at the indicated region (white square).
(B) Representative recovery curves for BODIPY diffusion following control (solid line)
or Bc-SMase (broken line) treatment are shown. A typical result from one of eighteen
experiments is shown.
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domains in the membrane, resulting in their disruption.
We reported that the hemolysis of sheep erythrocytes by alpha-
toxin is dependent on the activation of the C24:1-SM metabolic
system through activation of endogenous SMase by Gi in DRM,
especially the formation of S1P [18,19]. PT did not inhibit the
hemolysis or the formation of ceramide from SM induced by Bc-
SMase in the erythrocytes. The treatment with N-OE and DHS had
little effect on the hemolysis by Bc-SMase. Furthermore, the level of
hemolysis by Bc-SMase was the same as that by the toxin at
concentrations of 0.05–0.8 μM, but the level of ceramide production
in membranes of the sheep erythrocytes treated with Bc-SMase was
about 6- to 15-fold that in erythrocytes treated with alpha-toxin.
These results show that the activity of Bc-SMase is dependent on the
hydrolysis of SM in membranes, but that of the toxin is not. Therefore
the mechanism of action of the toxin is linked to the intracellular
signal transduction pathway, as reported previously [18,19], while
that of Bc-SMase is different. When the level of CF-release from
liposomes by Bc-SMase was the same as that induced by the toxin, the
level of ceramide production in liposomes treated with Bc-SMase was
the same as that in liposomes treated with the toxin, showing that the
disruption of artiﬁcial membranes, SM-liposomes, induced by the
enzyme and the toxin is closely related to production of ceramide
from SM. It was found that Bc-SMase was highly effective in
hydolyzing SM in membranes, compared with the toxin, supporting
that the event by Bc-SMase is linked to the hydrolysis of SM in
membranes.
Alpha-toxin bound almost exclusively to DRM of sheep erythro-
cytes, and speciﬁcally caused the formation of ceramide in DRM [19].
Treatment of the cells with MβCD had in little effect on the hemolysis
by Bc-SMase, but inhibited that induced by alpha-toxin. Bc-SMase
bound to not only DRM, but also DSF of sheep erythrocytes. Ceramide
formed in the cells treated with Bc-SMase was detected in whole
membranes, and not inhibited by PT, supporting that Bc-SMase
hydrolyzes SM in whole membranes. Furthermore, several studies
have reported that up to 50% of the total amount of SM in sheep
erythrocytes is located in the plasma membrane, being concentrated
in the outer leaﬂet [33,34]. We reported that the β-hairpin region of
Bc-SMase interacts with phosphorylcholine of SM [15]. Accordingly, itappears that Bc-SMase speciﬁcally binds to SM in the outer leaﬂet of
membranes of sheep erythrocytes, and hydrolyzes SM to ceramide in
membranes.
Treatment of BODIPY-SM-stained erythrocytes with Bc-SMase
resulted in hydrolysis of BODIPY-SM to BODIPY-ceramide (Fig. 6D),
and appearance in ﬂuorescence substance-rich domain (Fig. 6B).
Furthermore, the domains, in which ﬂuorescent substance were
concentrated, reacted with anti-ceramide antibody (Fig. 6E). These
results indicated that ﬂuorescent substance-rich domains in the cells
treated with Bc-SMase are ceramide-rich domains. FRAP analysis
showed that the recovery rate of BODIPY diffusion was reduced in the
ceramide-rich domain of sheep erythrocytes treated with Bc-SMase,
compared with the overall membrane of untreated cells (Fig. 7B),
suggesting that formation of the ceramide-rich domains induced by
Bc-SMase leads to a reduction in the ﬂuidity of the cell membranes.
Several studies have reported that the ceramide-rich domain forms a
rigid phase in membranes, and that ceramide-induced leakage of
aqueous contents from liposomes is due to the structural defects
existing at the interface between rigid (ceramide-rich) and ﬂuid
(ceramide-poor) domains. [31,35–39]. Therefore, it is possible that
hemolysis induced by Bc-SMase occurs through the coalescence of
ceramide-rich domains and formation of the interface between rigid
and ﬂuid domains.
In conclusion, treatment with Bc-SMase induces the formation of
ceramide-rich domains in membranes, and a decrease in the ﬂuidity
of membranes, leading to destabilization under physical stimulation
and ﬁnally the disruption of membranes.Acknowledgments
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